PoliticalRepoPoliticalRepo

United States · Law · HR

H.R. 3253 (116th)

Sustaining Excellence in Medicaid Act of 2019

enactedUnited States· United States Congress· EN

Introduced

13 June 2019

Last action

Status

Became Public Law No: 116-39.

Sponsors

Subjects

Discovery layer

Source updated

28 May 2025

Summary

Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act of 2019 This bill alters several Medicaid programs and funding mechanisms. Specifically, the bill makes appropriations through FY2024 for, and otherwise revises, the Money Follows the Person Rebalancing Demonstration Program; allows state Medicaid fraud control units to review complaints regarding patients who are in noninstitutional or other settings; temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home and community-based services; temporarily extends the Medicaid demonstration program for certified community behavioral health clinics; repeals the requirement, under the Medicaid Drug Rebate Program, that drug manufacturers include the prices of certain authorized generic drugs when determining the average manufacturer price (AMP) of brand-name drugs (also known as a "blended AMP"), and excludes manufacturers from the definition of "wholesalers" for purposes of rebate calculations; and increases funding available to the Medicaid Improvement Fund beginning in FY2021.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

17 official files

Enrolled Bill (text)

View fileDownload file

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.